Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

CDC: Ask Pregnant Women About Trips to Zika Outbreak Areas

By Drug Discovery Trends Editor | January 20, 2016

U.S. health officials issued new guidance Tuesday for doctors whose pregnant patients may have traveled to regions with a tropical illness linked to birth defects.
 
Doctors should ask pregnant women about their travel and certain symptoms, and – if warranted – test them for an infection with the Zika (ZEE’-ka) virus, the Centers for Disease Control and Prevention said Tuesday.
 
If there are signs of an infection or there are other reasons to believe the fetus is affected, ultrasounds should be considered to monitor the baby’s development, the CDC advised.
 
The virus is spread through mosquito bites, and there have been outbreaks in parts of the Caribbean and Latin America. There is no medicine or vaccine for it.
 
Usually the infection only causes a mild illness, if at all. Most infected people don’t develop symptoms. In those that do, the worst of it involves fever, rash, joint pain, and red eyes – which usually lasts no more than a week.
 
But there’s mounting evidence linking the infection to a birth defect called microcephaly, in which the head is smaller than normal and the brain may not have developed properly.
 
Usually rare, more than 3,500 babies with the condition have been reported in Brazil since October. The connection to Zika is still being investigated, and health officials note there are many causes of the condition, including genetics, and exposure during pregnancy to alcohol and certain germs and toxic chemicals.
 
In the Brazil cases, most of the mothers apparently were infected during the first trimester, but there is some evidence the birth defect can occur later in pregnancy, CDC officials have said.
 
Last week, CDC officials said pregnant women should consider postponing trips to 14 destinations – Brazil, Colombia, El Salvador, French Guiana, Guatemala, Haiti, Honduras, Martinique, Mexico, Panama, Paraguay, Puerto Rico, Suriname and Venezuela.
 
They also advised women who are trying to get pregnant or thinking of getting pregnant to talk to their doctor before traveling to those areas, and to take extra precautions to avoid mosquito bites.
 
Health officials say no infections have occurred in the United States, except for one in the U.S. territory of Puerto Rico. The kind of mosquitoes that can carry the virus are found in the southwestern United States. The mosquito also spreads other viruses that cause dengue fever and chikungunya.
 
In the last year, there have been a dozen confirmed cases among U.S. travelers, including two pregnant women in Illinois and one in Hawaii, whose baby was born with the birth defect. She was likely infected while living in Brazil, Hawaii health officials said.
 
The CDC’s priority was to alert pregnant women to the situation, even though there are a lot of lingering questions, said Dr. Tom Frieden, the agency’s director.
 
“There’s a lot we don’t know,” including how much Zika is in the different areas, or how likely it is that Zika infection in a pregnant woman will lead to the birth defect, he added. Perhaps there’s another factor which also plays a role in whether a child develops the birth defect, he said Tuesday.
 
Source: Associated Press

Filed Under: Drug Discovery

 

Related Articles Read More >

Sai Life Sciences exec: GLP-1 boom has ‘exploded the peptide field’ as firm opens new center
Novartis in the Pharma 50
Swissmedic approves first malaria treatment for infants
Korean team reports all-in-one cancer nanomedicine in pre-clinical studies
Nektar’s Phase 2b atopic dermatitis win triggers 1,746% analyst target surge, but legal tussle with ex-partner Lilly could complicate path forward
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE